ABO-incompatible organ transplantation

Current Opinion in Organ Transplantation

Volumn 12, Issue 4, 2007, Pages 409-414

  Takahashi, Kota ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

ABO antigens; ABO incompatibility; Anti A antibody; Anti B antibody; Antibody mediated rejection; Organ transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ANTIBODY TITER; B LYMPHOCYTE; BLOOD GROUP ABO INCOMPATIBILITY; CELLULAR IMMUNITY; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COST; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; REVIEW; SPLENECTOMY;

EID: 34347338091     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32823ecfe0     Document Type: Review

References (61)

1. Takahashi K, Saito K. The Japanese ABO-incompatible Kidney Transplantation Committee. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplant 2006; 13:118-112. This study reports the results of statistical analyses of 564 Japanese recipients of ABO-incompatible renal transplants since 1989.
2. West LJ, Karamiou T, Dipchand AI, et al. Impact on outcomes after listing and transplantation, of a strategy to accept ABO blood group-incompatible donor heart for neonates and infants. J Thorac Cardiovasc Surg 2006; 131:455-461. This study reports the outcomes of children who underwent ABO-incompatible heart transplantation at the Division of Cardiology, Department of Pediatrics, Toronto Hospital for Sick Children, University of Toronto, Canada.
3. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004; 77:403-411.
4. Hanto DW, Fecteau AH, Alonso MH, et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transplant 2003; 1:22-30.
5. Shishido S, Hasegawa A. current status of ABO-incompatible kidney transplantation in children. Pediatr Transplant 2005; 9:148-154.
6. Breimer ME, Rydberg L, guest editors. The Proceedings of the Symposium on ABO-Incompatibility in Transplantation. Xenotransplant 2006: 13(2):100-170. This report summarizes the proceedings of papers presented at the Second International Symposium on ABO-Incompatibility in Transplantation, held in Sweden.
7. Stussi G, West L, Cooper DKC, et al. ABO-incompatible allotransplantation as a basis for clinical xenotransplantation. Xenotransplant 2006; 13:390-399.
8. Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. This book summarizes papers presented at the International Meeting of ABO-Incompatible Organ Transplantation held in Japan.
9. Futagawa Y, Terasaki PI. ABO incompatible kidney transplantation - an analysis of UNOS registry data. Clin Transplant 2006; 20:122-126.
10. Tyden G, Kumlien G, Genberg H, et al. The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy. Xenotransplant 2006; 13:105-107.
11. Saito K, Nakagawa Y, Takahashi K, et al. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Xenotransplant 2006; 13:11-117.
12. Takahashi K, Takahara S, Uchida K, et al. Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan. Transplant Proc 2005; 37:1800-1803.
13. Kaihara S, Okamoto M, Akioka K, et al. Improved graft survival in ABO-incompatible living donor kidney transplantation. Transplant Proc 2005; 37:1804-1805.
14. Tyden G, Kumlien G, Genberg H, et al. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5:145-148.
15. Segev DL, Simpkins CE, Warren DS, et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5:145-148.
16. Norden G, Brigs D, Cockwell P, et al. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplant 2006; 13:148-153.
17. Ivanovski N, Popov Z, Masin-Spasovska J, et al. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans. Xenotransplant 2006; 13:123-125.
18. Imamura R, Ishiguro S, Shi Y, et al. ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report. Xenotransplant 2006; 13:133-135.
19. Ahlenstiel T, Offner G, Strehlau J, et al. ABO-incompatible kidney transplantation of an 8-yr-old girl with donor/recipient-consultation A1B/B. Xenotransplant 2006; 13:141-147.
20. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4:1089-1096.
21. Teraoka S, Kai K, Iwato K, et al. New developed preconditioning regimen consisting of rituximab, splenectomy and plasmapheresis for nonresponders to conventional regimen in ABO-incompatible kidney transplantation. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 99-104.
22. Stegall MD. Overcoming antibody barriers to transplantation: ABO-incompatible and positive cross-match kidney transplantation at Mayo Clinic - Rochester. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 113-119.
23. Tanabe M, Shimazu M, Wakabayashi G, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002; 27:1959-1961.
24. Ueda M, Yoshizawa A, Haga H, et al. Prophylactic use of anti-CD20 monoclonal antibody in ABO-incompatible liver transplantation. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 105-109.
25. Skogsberg U, Breimer ME, Friman S, et al. Successful ABO-incompatible liver transplantation using A2 donors. Transplant Proc 2006; 38:2667-2670.
26. Kozaki K, Egawa H, Ueda M, et al. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience. Ther Apher Dial 2006; 10:441-448.
27. Heffron T, Welch D, Pillen T, et al. Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective post operative plasmapheresis. Liver Transplant 2006; 12:972-978.
28. Pierson RN, Moore J, Merion RM, et al. ABO-incompatible lung transplantation. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 63-69.
29. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 2005; 19:76-85.
30. Takahashi K. A new immunosuppressive therapy in ABO-incompatible kidney transplantation based on a new concept of accommodation. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 73-87. This chapter describes mechanisms underlying graft survival, i.e. mechanisms of accommodation, as well as therapeutic strategies for ABO-incompatible renal transplantation that are based on the concept of accommodation.
31. Galili U. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Tranfus Apher Sci 2006; 35:45-58. This review article reports similarities and differences between xenotransplantation and ABO-incompatible transplantation, and briefly describes the mechanisms underlying graft survival in ABO-incompatible transplantation.
32. Ishida H, Tanabe K, Ishizuka T, et al. Differences in humoral immunity between a nonrejection group and a rejection group after ABO-incompatible renal transplantation. Transplantation 2006; 81:665-671.
33. West LJ. B-cell tolerance following ABO-incompatible infant cardiac transplantation. Transplantation 2006; 81:301-307. This study demonstrates that B-cell tolerance is linked to the mechanism of graft survival in children undergoing ABO-incompatible heart transplantation.
34. Hanto DW. ABO-incompatible transplantation: accommodation by upregulation of protective genes - a hypothesis. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 53-60.
35. Aikawa A, Ohara T, Yamashita M, et al. Donor-specific suppression of blood group antibodies in ABO-incompatible kidney transplantation. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 8-12.
36. Inoue S, Tahara K, Fujishiro J, et al. Severe rejection of rat intestinal grafts overexpressing human histo-blood group A/B transferase. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 13-23.
37. Takahashi K. Recent findings in ABO-incompatible kidney transplantation - classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group related antigens during critical period preceding establishment of accommodation. Clin Exp Nephrol 2007; 11:128-141.
38. Kobayashi T. Standardization of the assay method for anti-A/B antibody titers and its problems. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 3-7. The indirect Coombs' method and the saline method are internationally used to measure anti-A/B antibody titers. These measurement techniques are straightforward, but there are wide variations in the results among different hospitals. To overcome this disadvantage, the author introduces a standard method that reduces variability in measured values among hospitals.
39. Shimmura H, Tanabe K, Tshikawa N, et al. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 2000; 70:1331-1335.
40. Shimmura H, Tanabe K, Ishida H, et al. Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titters under our current immunosuppression. Transplantation 2005; 80:985-988.
41. Imai N, Nishi S, Alchi BM, et al. Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition. Nephrol Dial Transplant 2006; 21:2589-2595.
42. Kayler LK, Farber JL, Colombe B, et al. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation. Transplant Int 2006; 19:128-139.
43. Gloor JM, Cosio FG, Rea DJ, et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006; 6:1841-1847.
44. Hass M, Rahman MH, Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006; 6:1829-1840.
45. Haga H, Egawa H, Fujimoto Y, et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transplant 2006; 12:457-464.
46. Haga H, Sakashita H, Wen M-C, et al. Correlation of conventional histology, clinical outcomes, and C4d immunostaining in ABO-incompatible liver transplantation. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 25-31.
47. Nishi S, Hasegawa S, Takahashi K, et al. The safety measures for double filtration plasma apheresis (DFPP) before ABO incompatible kidney transplantation. In: Takahashi K, editor. ABO-incompatible organ transplantation from Japan. Amsterdam: Elsevier; 2006. pp. 91-95.
48. Rydlerg L, Bengtsson A, Nilsson K, et al. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transplant Int 2005; 17:666-672.
49. Tyden G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76:730-743.
50. Tyden G, Kumilien G, Genberg H, et al. ABO incompatible kidney transplantation without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5:145-148.
51. Donauer J, Wilpert J, Geyer M, et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Xenotransplant 2006; 13:108-110.
52. Norden G, Briggs D, Rydberg L, et al. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplant 2006; 13:148-153.
53. Ashizawa T, Matsuno N, Yokoyama T, et al. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation. Transplant Proc 2006; 38:3629-3632.
54. Boberg KM, Foss A, Midtvedt K, Schrumpf E. ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody. Clin Transplant 2006; 20:265-268.
55. Takahashi K. Timing of the start of immunosuppressive therapy (duration of desensitization therapy). In: Takahashi K, editor. Accommodation in ABO-incompatible kidney transplantation. Amsterdam: Elsevier; 2004. pp. 94-95.
56. Alexandre GPJ, Squifflet JP, De Bruyere M, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985; 17:138-143.
57. Morris PJ, Monaco AP. Cost of ABO incompatible living donor transplantation are justified. Transplantation 2006; 82:154. The authors, honorary chiefs of Transplantation, examined treatments and related costs at four hospitals performing ABO-incompatible renal transplantation.
58. Schwartz J, Stegall MD, Kremers WK, et al. Complications, Resource utilization, and cost of ABO-incompatible living donor kidney transplantation. Transplantation 2006; 82:155-163. This study reports treatments and costs of ABO-incompatible renal transplantation at the Department of Transplantation, Mayo Clinic, USA.
59. Montgomery RA, Simpkins CE, Segev DL. New options for patients with donor incompatibilities. Transplantation 2006; 82:164-165. This paper reports treatments and costs of ABO-incompatible renal transplantation at the Department of Surgery, Johns Hopkins University, USA.
60. Tyden G. Cost effectiveness of ABO-incompatible kidney transplantation. Transplantation 2006; 82:166-167. This paper reports treatments and costs of ABO-incompatible renal transplantation at the Department of Transplantation, Karolinska University, Sweden.
61. Schnitzler M, Machnicki G. ABO-incompatible living donor transplantation: is it economical 'compatible'? Transplantation 2006; 82:168-169. This paper reports treatments and costs of ABO-incompatible renal transplantation at Saint Louis University School of Medicine, USA.